Literature DB >> 16849336

Neuroserpin binds Abeta and is a neuroprotective component of amyloid plaques in Alzheimer disease.

Kerri J Kinghorn1, Damian C Crowther, Lynda K Sharp, Charlotte Nerelius, Richard L Davis, Howard T Chang, Clare Green, David C Gubb, Jan Johansson, David A Lomas.   

Abstract

Alzheimer disease is characterized by extracellular plaques composed of Abeta peptides. We show here that these plaques also contain the serine protease inhibitor neuroserpin and that neuroserpin forms a 1:1 binary complex with the N-terminal or middle parts of the Abeta(1-42) peptide. This complex inactivates neuroserpin as an inhibitor of tissue plasminogen activator and blocks the loop-sheet polymerization process that is characteristic of members of the serpin superfamily. In contrast neuroserpin accelerates the aggregation of Abeta(1-42) with the resulting species having an appearance that is distinct from the mature amyloid fibril. Neuroserpin reduces the cytotoxicity of Abeta(1-42) when assessed using standard cell assays, and the interaction has been confirmed in vivo in novel Drosophila models of disease. Taken together, these data show that neuroserpin interacts with Abeta(1-42) to form off-pathway non-toxic oligomers and so protects neurons in Alzheimer disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16849336     DOI: 10.1074/jbc.M600690200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Determining serpin conformational distributions with single molecule fluorescence.

Authors:  Nicole Mushero; Anne Gershenson
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

2.  BRICHOS domains efficiently delay fibrillation of amyloid β-peptide.

Authors:  Hanna Willander; Jenny Presto; Glareh Askarieh; Henrik Biverstål; Birgitta Frohm; Stefan D Knight; Jan Johansson; Sara Linse
Journal:  J Biol Chem       Date:  2012-07-16       Impact factor: 5.157

3.  Local conformational flexibility provides a basis for facile polymer formation in human neuroserpin.

Authors:  Anindya Sarkar; Crystal Zhou; Robert Meklemburg; Patrick L Wintrode
Journal:  Biophys J       Date:  2011-10-05       Impact factor: 4.033

Review 4.  Modeling the complex pathology of Alzheimer's disease in Drosophila.

Authors:  Pedro Fernandez-Funez; Lorena de Mena; Diego E Rincon-Limas
Journal:  Exp Neurol       Date:  2015-05-27       Impact factor: 5.330

5.  pH-dependent stability of neuroserpin is mediated by histidines 119 and 138; implications for the control of beta-sheet A and polymerization.

Authors:  Didier Belorgey; Peter Hägglöf; Maki Onda; David A Lomas
Journal:  Protein Sci       Date:  2010-02       Impact factor: 6.725

6.  Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.

Authors:  Martín Gómez Ravetti; Osvaldo A Rosso; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

Review 7.  Animal models of human amyloidoses: are transgenic mice worth the time and trouble?

Authors:  Joel N Buxbaum
Journal:  FEBS Lett       Date:  2009-07-20       Impact factor: 4.124

Review 8.  Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's disease.

Authors:  Anne M Fagan; Richard J Perrin
Journal:  Biomark Med       Date:  2012-08       Impact factor: 2.851

9.  Probing neuroserpin polymerization and interaction with amyloid-beta peptides using single molecule fluorescence.

Authors:  Albert Chiou; Peter Hägglöf; Angel Orte; Allen Yuyin Chen; Paul D Dunne; Didier Belorgey; Susanna Karlsson-Li; David A Lomas; David Klenerman
Journal:  Biophys J       Date:  2009-10-21       Impact factor: 4.033

10.  Uptake of the necrotic serpin in Drosophila melanogaster via the lipophorin receptor-1.

Authors:  Sandra Fausia Soukup; Joaquim Culi; David Gubb
Journal:  PLoS Genet       Date:  2009-06-26       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.